Addict Abingdon Engl
The combination of a basal insulin analogue and GLP-1 RA in one injection may be a simple way to reduce the burden and complexity of treatment [332]
Last reviewed: June 16, 2026 Last updated: June 16, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Elevated adiponectin concentrations have been noted in major clinical trials with GLP-1RAs (123, 188) and, more robustly, with tirzepatide (189)
GLP-1 medications are ideal for: Adults with a BMI over 27 with weight-related conditions (e.g
Alternative strategies, such as through acquisitions or licensing agreements will need to be considered